Search alternatives:
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 mg » 100 mg (Expand Search), 50 mg (Expand Search)
Showing 581 - 600 results of 69,205 for search '(( 10 mg decrease ) OR ( 5 ((ng decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 0.90s Refine Results
  1. 581
    The original gel image underlying Fig 5C blot results.

    The original gel image underlying Fig 5C blot results. by Te-Hsing Hsu (16973374)

    Published 2023
    Save to List
    Saved in:
  2. 582
    The original gel image underlying Fig 5B blot results.

    The original gel image underlying Fig 5B blot results. by Te-Hsing Hsu (16973374)

    Published 2023
    Save to List
    Saved in:
  3. 583
    Design, Synthesis, and Cellular Characterization of a New Class of IPMK Kinase Inhibitors

    Design, Synthesis, and Cellular Characterization of a New Class of IPMK Kinase Inhibitors by Yubai Zhou (3931427)

    Published 2025
    “…The kinase activity of human inositol phosphate multikinase (IPMK) is required for the synthesis of higher-order inositol phosphate signaling molecules, regulation of gene expression, and control of the cell cycle. Here, we report a novel series of highly potent IPMK inhibitors. …”
    Save to List
    Saved in:
  4. 584
    Image_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.png

    Image_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  5. 585
    Table_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  6. 586
    Table_3_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_3_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  7. 587
    Table_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  8. 588
    Image_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.png

    Image_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  9. 589
    Table_3_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_3_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  10. 590
    Table_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  11. 591
    Table_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.pdf

    Table_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  12. 592
    Image_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.png

    Image_1_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  13. 593
    Image_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.png

    Image_2_Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Th... by Yingying Yu (546494)

    Published 2022
    Save to List
    Saved in:
  14. 594
    Aggrecan knockdown ATDC5 chondroprogenitor cells have decreased Alcian blue staining and absorbance levels compared to control cells after ITS stimulation.

    Aggrecan knockdown ATDC5 chondroprogenitor cells have decreased Alcian blue staining and absorbance levels compared to control cells after ITS stimulation. by Juanita K. Hodax (6848540)

    Published 2019
    Save to List
    Saved in:
  15. 595
    Results of different P forms in soil (mg kg<sup>-1</sup>).

    Results of different P forms in soil (mg kg<sup>-1</sup>). by Wenzhi Zhao (453144)

    Published 2024
    “…Both D<sub>max</sub>, D<sub>r</sub>, and RDP exhibited a decreasing trend with increasing soil depth before showing an upward trend. …”
    Save to List
    Saved in:
  16. 596
    The success rate for blood lipid goals achievement, including TG<150 mg/dl, TC<200 mg/dl, LDL-C<70 mg/dl, and non-HDL-C<130 mg/dl.

    The success rate for blood lipid goals achievement, including TG<150 mg/dl, TC<200 mg/dl, LDL-C<70 mg/dl, and non-HDL-C<130 mg/dl. by Amirhossein Yadegar (13922190)

    Published 2023
    Save to List
    Saved in:
  17. 597
    Data_Sheet_2_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neurons.XLSX

    Data_Sheet_2_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…We demonstrated artesunate prevented PINP in a dose-dependent manner, while exerting a clear anti-hyperalgesic effect on already existing PINP. …”
    Save to List
    Saved in:
  18. 598
    Data_Sheet_1_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neurons.XLSX

    Data_Sheet_1_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…We demonstrated artesunate prevented PINP in a dose-dependent manner, while exerting a clear anti-hyperalgesic effect on already existing PINP. …”
    Save to List
    Saved in:
  19. 599
    Data_Sheet_6_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neurons.XLSX

    Data_Sheet_6_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…We demonstrated artesunate prevented PINP in a dose-dependent manner, while exerting a clear anti-hyperalgesic effect on already existing PINP. …”
    Save to List
    Saved in:
  20. 600
    Data_Sheet_3_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neurons.XLSX

    Data_Sheet_3_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…We demonstrated artesunate prevented PINP in a dose-dependent manner, while exerting a clear anti-hyperalgesic effect on already existing PINP. …”
    Save to List
    Saved in:

Search Tools: